Serum Amyloid A Is a Biomarker of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
- 1 February 2008
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 177 (3), 269-278
- https://doi.org/10.1164/rccm.200705-678oc
Abstract
Much of the total disease burden and cost of chronic obstructive pulmonary disease (COPD) is associated with acute exacerbations of COPD (AECOPD). Serum amyloid A (SAA) is a novel candidate exacerbation biomarker identified by proteomic screening. To assess SAA as a biomarker of AECOPD. Biomarkers were assessed (1) cross-sectionally (stable vs. AECOPD; 62 individuals) and (2) longitudinally with repeated measures (baseline vs. AECOPD vs. convalescence; 78 episodes in 37 individuals). Event severity was graded (I, ambulatory; II, hospitalized; III, respiratory failure) based on consensus guidelines. Presumptively newly acquired pathogens were associated with onset of symptomatic AECOPD. In the cross-sectional study, both SAA and C-reactive protein (CRP) were elevated at AECOPD onset compared with stable disease (SAA median, 7.7 vs. 57.6 mg/L; P < 0.01; CRP median, 4.6 vs. 12.5 mg/L; P < 0.01). Receiver operator characteristics analysis was used to generate area-under-curve values for event severity. SAA discriminated level II/III events (SAA, 0.88; 95% confidence interval, 0.80-0.94 vs. CRP, 0.80; 95% confidence interval, 0.70-0.87; P = 0.05). Combining SAA or CRP with major symptoms (Anthonisen criteria, dyspnea) did not further improve the prediction model for severe episodes. IL-6 and procalcitonin were not informative. SAA is a novel blood biomarker of AECOPD that is more sensitive than CRP alone or in combination with dyspnea. SAA may offer new insights into the pathogenesis of AECOPD.This publication has 61 references indexed in Scilit:
- IL4Rα Mutations Are Associated with Asthma Exacerbations and Mast Cell/IgE ExpressionAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Profiling serum biomarkers in patients with COPD: associations with clinical parametersThorax, 2007
- C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary diseaseThorax, 2006
- Is this the beginning of unravelling the puzzle of COPD exacerbations?European Respiratory Journal, 2005
- Local expression of the serum amyloid A and formyl peptide receptor–like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritisArthritis & Rheumatism, 2004
- Serum Amyloid A as a Predictor of Coronary Artery Disease and Cardiovascular Outcome in WomenCirculation, 2004
- Recognizing Influenza in Older Patients with Chronic Obstructive Pulmonary Disease Who Have Received Influenza VaccineClinical Infectious Diseases, 2003
- Predicting Influenza Infections during Epidemics with Use of a Clinical Case DefinitionClinical Infectious Diseases, 2000
- Expression and Regulation of Constitutive and Acute Phase Serum Amyloid A mRNAs in Hepatic and Non‐Hepatic Cell LinesScandinavian Journal of Immunology, 1996
- Lipoxin A4: a novel anti-inflammatory molecule?Thorax, 1995